Thinking of joining a study?

Register your interest

Become a volunteer?

Clinical trials for Cancer in United States

6986 results

Sort By:

Parathyroid Tumor Clonal Status

Study ID: NCT05997810
Start Date: 2023-04-11
End Date: 2027-01
Study Type

Observational

Study Phase

Not Applicable

No. of Participants

839

Intervention / Treatment
Sponsor

Washington University School of Medicine

Source: clinicaltrials.gov

Share:
Add to list

The Immune System's Response to Young Women's Breast Cancer

Study ID: NCT01503190
Start Date: 2009-07-21
End Date: 2027-07
Study Type

Observational

Study Phase

Not Applicable

No. of Participants

800

Intervention / Treatment
Sponsor

University of Colorado, Denver

Source: clinicaltrials.gov

Share:
Add to list

Human Papillomavirus (HPV) Vaccination vs. Placebo for the Treatment of Refractory Cutaneous Warts

Study ID: NCT05625633
Start Date: 2024-03-25
End Date: 2026-12
Study Type

Interventional

Study Phase

Phase3

No. of Participants

120

Intervention / Treatment

Human Papillomavirus 9-valent Vaccine, Recombinant

Normal Saline

Sponsor

Western Institute for Veterans Research

Source: clinicaltrials.gov

Share:
Add to list

Safety and Efficacy Study in Recurrent or Progressive Grade III or IV IDH1 Mutated Glioma

Study ID: NCT02704858
Start Date: 2017-08-01
End Date: 2025-12
Study Type

Interventional

Study Phase

Phase2

No. of Participants

49

Intervention / Treatment

Perillyl alcohol

Sponsor

Neonc Technologies, Inc.

Source: clinicaltrials.gov

Share:
Add to list

Single Dose Investigator Initiated Pilot Study to Investigate CYTALUX (Pafolacianine) for Intraoperative Detection of Malignant Tissue in Subjects Undergoing Surgical Resection for Cancer.

Study ID: NCT07039526
Start Date: 2025-08-19
End Date: 2027-12
Study Type

Interventional

Study Phase

Phase2

No. of Participants

50

Intervention / Treatment

CYTALUX™ (pafolacianine) injection preoperatively

Sponsor

John Waters

Source: clinicaltrials.gov

Share:
Add to list

Biomarker Approach to Screening for the Early Detection of HPV-related Oropharyngeal Cancer (BASH OPC)

Study ID: NCT06305676
Start Date: 2024-01-22
End Date: 2029-01
Study Type

Observational

Study Phase

Not Applicable

No. of Participants

400

Intervention / Treatment

combined HPV 16 DNA and host gene methylation oral biomarker panel

Sponsor

H. Lee Moffitt Cancer Center and Research Institute

Source: clinicaltrials.gov

Share:
Add to list

CD33KO-HSPC Infusion Followed by CART-33 Infusion(s) for Refractory/Relapsed AML

Study ID: NCT05945849
Start Date: 2024-02-23
End Date: 2044-02-23
Study Type

Interventional

Study Phase

Phase1

No. of Participants

16

Intervention / Treatment

CD33KO-HSPC; CART33

Sponsor

University of Pennsylvania

Source: clinicaltrials.gov

Share:
Add to list

Safety, PK and Efficacy of QXL138AM in Patients With Solid Tumors and Multiple Myeloma

Study ID: NCT06582017
Start Date: 2024-08-28
End Date: 2028-05-30
Study Type

Interventional

Study Phase

Phase1

No. of Participants

100

Intervention / Treatment

QXL138AM Injection every 2 weeks by IV Infusion

Sponsor

Nammi Therapeutics Inc

Source: clinicaltrials.gov

Share:
Add to list

Adjuvant Therapy Based on Pathologic Response After Neoadjuvant Encorafenib Binimetinib in Melanoma

Study ID: NCT04741997
Start Date: 2021-05-24
End Date: 2026-07
Study Type

Interventional

Study Phase

Early_phase1

No. of Participants

50

Intervention / Treatment

Encorafenib Pill

Binimetinib Pill

Nivolumab

Sponsor

H. Lee Moffitt Cancer Center and Research Institute

Source: clinicaltrials.gov

Share:
Add to list

Frailty in Patients With Gastrointestinal Cancer Who Are Undergoing Major Surgery

Study ID: NCT05694338
Start Date: 2023-03-13
End Date: 2027-06-01
Study Type

Observational

Study Phase

Not Applicable

No. of Participants

100

Intervention / Treatment

Frailty survey

Sponsor

The Guthrie Clinic

Source: clinicaltrials.gov

Share:
Add to list